Roche considering divesting $1.9 billion cancer data startup, FT reports
(Reuters) – Swiss pharmaceutical company Roche is considering divesting cancer data specialist Flatiron Health, the Financial Times reported on Wednesday, citing people familiar with the matter.
Roche had paid $1.9 billion for New-York based Flatiron Health in 2018.
